Marked Chart Marked Chart Closed

The Marked Chart Wire · Business

Vertex Pharmaceuticals

Vertex Pharmaceuticals reports third-quarter revenue of $3.43 billion

Vertex Pharmaceuticals reported third-quarter revenue of $3.43 billion, matching expectations. Earnings per share came in at $4.76, slightly below the expected $4.78.

VRTX-1.0%

Illustration for the Business desk

The stocks in this story

  1. VRTX-1.0%Vertex$553.15

Prices from Based on Mon, Nov 2 close · Opens Tue 9:30 AM ET. Each tile opens the stock's chart and news.

New to this? Read: Reading a stock chart

More Business news

Fast headlines, summarized. Not verified and not advice. Check the full story before you act.